Geneva Capital Management LLC Acquires 38,105 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Key Points

• Geneva Capital Management LLC increased its holdings in Option Care Health by 5.1% during the first quarter, owning 781,625 shares valued at approximately $27.3 million.
• Institutional investors collectively own 98.05% of Option Care Health, highlighting significant confidence in the company's prospects.
• Option Care Health reported $1.42 billion in revenue for the last quarter, surpassing analysts' expectations, and a net margin of 3.93% with earnings per share of $0.41.

Geneva Capital Management LLC boosted its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 5.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 781,625 shares of the company's stock after purchasing an additional 38,105 shares during the quarter. Geneva Capital Management LLC owned approximately 0.48% of Option Care Health worth $27,318,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Allspring Global Investments Holdings LLC grew its position in Option Care Health by 6,525,926.1% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 1,500,986 shares of the company's stock valued at $52,459,000 after buying an additional 1,500,963 shares in the last quarter. Voloridge Investment Management LLC acquired a new stake in Option Care Health in the fourth quarter worth approximately $27,428,000. Freestone Grove Partners LP acquired a new position in shares of Option Care Health during the 4th quarter valued at $17,487,000. Dimensional Fund Advisors LP grew its holdings in Option Care Health by 17.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock worth $92,518,000 after acquiring an additional 591,042 shares during the period. Finally, Alyeska Investment Group L.P. lifted its holdings in Option Care Health by 159.0% in the 4th quarter. Alyeska Investment Group L.P. now owns 732,948 shares of the company's stock valued at $17,004,000 after acquiring an additional 450,000 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their target price for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. Barrington Research reiterated an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research report on Thursday, July 10th. JMP Securities upped their price target on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research report on Thursday, July 31st. Finally, Citigroup restated an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. One analyst has rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $35.75.

Option Care Health Stock Down 0.8%

Shares of OPCH traded down $0.21 during trading hours on Thursday, hitting $27.70. 629,777 shares of the company were exchanged, compared to its average volume of 1,852,969. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. The company has a market cap of $4.50 billion, a PE ratio of 22.07, a PEG ratio of 1.78 and a beta of 0.79. The firm's 50 day moving average is $30.82 and its 200-day moving average is $31.94.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. The business had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%. Option Care Health's revenue for the quarter was up 15.4% on a year-over-year basis. During the same period in the prior year, the company earned $0.30 EPS. On average, equities research analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.